These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21640479)

  • 21. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis: therapeutic effect of transcatheter arterial chemoembolization combined with compound kushen injection in hepatocellular carcinoma.
    Sun Q; Ma W; Gao Y; Zheng W; Zhang B; Peng Y
    Afr J Tradit Complement Altern Med; 2012; 9(2):178-88. PubMed ID: 23983333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis of transcatheter arterial chemoembolization with or without sorafenib for the treatment of unresectable hepatocellular carcinoma.
    Zhao RC; Zhou J; Wei YG; Liu F; Chen KF; Li Q; Li B
    Hepatobiliary Pancreat Dis Int; 2017 Oct; 16(5):493-498. PubMed ID: 28992881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective analysis of transarterial chemoembolization and sorafenib in Chinese patients with unresectable and recurrent hepatocellular carcinoma.
    Wan X; Zhai X; Yan Z; Yang P; Li J; Wu D; Wang K; Xia Y; Shen F
    Oncotarget; 2016 Dec; 7(50):83806-83816. PubMed ID: 27566566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis.
    Ni JY; Xu LF; Wang WD; Sun HL; Chen YT
    World J Gastroenterol; 2014 Dec; 20(45):17206-17. PubMed ID: 25493037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma.
    Shim SJ; Seong J; Han KH; Chon CY; Suh CO; Lee JT
    Liver Int; 2005 Dec; 25(6):1189-96. PubMed ID: 16343071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas.
    Cheung TT; Poon RT; Jenkins CR; Chu FS; Chok KS; Chan AC; Tsang SH; Dai WC; Yau TC; Chan SC; Fan ST; Lo CM
    Liver Int; 2014 Jul; 34(6):e136-43. PubMed ID: 24451026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of
    Li S; He X; Dang L; Xu F; Fang J; Li F; Wang W
    Dig Dis Sci; 2018 Feb; 63(2):321-328. PubMed ID: 29305738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [External radiation and combined transcatheter arterial chemoembolization for unresectable primary liver cancer].
    Liu MZ; Wang XS; Cai L; Gu MF; Liu H; Li Q; Cui NJ; Zhang YQ; Li GH; Li JQ
    Ai Zheng; 2005 Jan; 24(1):82-6. PubMed ID: 15642207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mixed analysis comparing nine minimally invasive surgeries for unresectable hepatocellular carcinoma patients.
    Tao R; Li X; Ran R; Xiao Z; Zhang H; Kong H; Song Q; Huang Y; Wang L; Huang J
    Oncotarget; 2017 Jan; 8(3):5460-5473. PubMed ID: 27705924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparison.
    Zhao J; Zhang H; Wei L; Xie S; Suo Z
    Oncotarget; 2017 Feb; 8(9):15101-15113. PubMed ID: 27835871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A meta-analysis of Cinobufacini combined with transcatheterarterial chemoembolization in the treatment of advanced hepatocellular carcinoma.
    Wu T; Sun R; Wang Z; Yang W; Shen S; Zhao Z
    J Cancer Res Ther; 2014 Aug; 10 Suppl 1():60-4. PubMed ID: 25207894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arsenic trioxide combined with transarterial chemoembolization for primary liver cancer: A meta-analysis.
    Lv XH; Wang CH; Xie Y
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1540-1547. PubMed ID: 28299819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
    Kim JH; Yoon HK; Kim SY; Kim KM; Ko GY; Gwon DI; Sung KB
    Aliment Pharmacol Ther; 2009 Jun; 29(12):1291-8. PubMed ID: 19392861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter Arterial Chemoembolization in Combination With High-Intensity Focused Ultrasound for Intermediate and Advanced Hepatocellular Carcinoma: A Meta-Analysis.
    Wang YB; Ma R; Wang ZB; Shi QL; Zhang L; Chen WZ; Gong JP; Bai J
    Front Oncol; 2022; 12():797349. PubMed ID: 35419281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Meta-analysis of the efficacy of transcatheter arterial chemoembolization combined with percutaneous ethanol injection in treating unresectable primary liver cancer].
    Gu GW; Li XC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):805-9. PubMed ID: 19595117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoembolization of hepatocellular carcinoma--what to tell the skeptics: review and meta-analysis.
    Ramsey DE; Geschwind JF
    Tech Vasc Interv Radiol; 2002 Sep; 5(3):122-6. PubMed ID: 12524642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation.
    Hyun D; Cho SK; Shin SW; Park KB; Park HS; Choo SW; Do YS; Choo IW; Lee MW; Rhim H; Lim HK
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):417-25. PubMed ID: 26246215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of sorafenib and TACE treatment of unresectable hepatocellular carcinoma in a Chinese population: subgroup analysis of the GIDEON study.
    Liu F; Meng Z; Shao G; Wang J; Wang Z; Yang J; Yip CS; He D
    Mol Biol Rep; 2017 Feb; 44(1):149-158. PubMed ID: 27981445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.